'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Radiculopathy to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Radiculopathy to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Radiculopathy Therapeutics Clinical Trials 26
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 60
List of Tables
Radiculopathy Therapeutics, Global, Clinical Trials by Region, 2016* 6
Radiculopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Radiculopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Radiculopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Radiculopathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Radiculopathy Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Radiculopathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Proportion of Radiculopathy to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 13
Radiculopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Radiculopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Radiculopathy to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 16
Radiculopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Radiculopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Radiculopathy Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Radiculopathy Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Radiculopathy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Radiculopathy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Radiculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Radiculopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Radiculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Radiculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
Radiculopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
List of Figures
Radiculopathy Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Radiculopathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Radiculopathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Radiculopathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Radiculopathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Radiculopathy Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Proportion of Radiculopathy to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 13
Radiculopathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Radiculopathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Radiculopathy to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 16
Radiculopathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Radiculopathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Radiculopathy Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Radiculopathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Radiculopathy Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Radiculopathy Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Radiculopathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Radiculopathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Radiculopathy Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Radiculopathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Radiculopathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
GlobalData Methodology 58